نتائج البحث - Plotkin, Scott
- يعرض 1 - 20 نتائج من 108
- اذهب إلى الاصفحة التالية
-
1
-
2
-
3
Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis... حسب Fayad, Laura M., Blakeley, Jaishri, Plotkin, Scott, Widemann, Brigitte, Jacobs, Michael A.
منشور في 2013نص -
4
ACTR-36. A SINGLE ARM PHASE 2 STUDY OF THE DUAL mTORC1/mTORC2 INHIBITOR VISTUSERTIB PROVIDED ON AN INTERMITTENT SCHEDULE FOR NEUROFIBROMATOSIS 2 PATIENTS WITH PROGRESSIVE OR SYMPTO... حسب Plotkin, Scott, Jordan, Justin, Beauchamp, Roberta, Muzikansky, Alona, Stemmer-Rachamimov, Anat, Ramesh, Vijaya
منشور في 2018نص -
5
-
6
-
7
NIMG-66. LONG-TERM FOLLOW-UP OF NEUROFIBROMATOSIS TYPE 1 PATIENTS USING WHOLE-BODY MRI DEMONSTRATES DYNAMIC CHANGES IN INTERNAL NEUROFIBROMA SIZE حسب Ly, Ina, Thalheimer, Raquel, Cai, Wenli, Bredella, Miriam, Merker, Vanessa, Plotkin, Scott, Jordan, Justin
منشور في 2019نص -
8
-
9
Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schw... حسب Merker, Vanessa L., Dai, Annie, Radtke, Heather B., Knight, Pamela, Jordan, Justin T., Plotkin, Scott R.
منشور في 2018نص -
10
Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1 حسب Maguiness, Sheilagh, Berman, Yemima, Rubin, Nathan, Dodds, Melissa, Plotkin, Scott R., Wong, Claire, Moertel, Christopher
منشور في 2021نص -
11
-
12
Effective Provider-Patient Communication of a Rare Disease Diagnosis: A Qualitative Study of People Diagnosed with Schwannomatosis حسب Merker, Vanessa L., Plotkin, Scott R., Charns, Martin P., Meterko, Mark, Jordan, Justin T., Elwy, A. Rani
منشور في 2020نص -
13
-
14
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition حسب Beauchamp, Roberta L., Erdin, Serkan, Witt, Luke, Jordan, Justin T., Plotkin, Scott R., Gusella, James F., Ramesh, Vijaya
منشور في 2020نص -
15
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists حسب Merker, Vanessa L., Knight, Pamela, Radtke, Heather B., Yohay, Kaleb, Ullrich, Nicole J., Plotkin, Scott R., Jordan, Justin T.
منشور في 2022نص -
16
-
17
-
18
Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case Report حسب Lessing, Andrés J., Cote, Gregory M., DeLaney, Thomas F., Plotkin, Scott R., Raskin, Kevin A., Lessing, Juan N.
منشور في 2021نص -
19
CLRM-16 PATIENT-FOCUSED DRUG DEVELOPMENT IN NEURO-ONCOLOGY: A PILOT STUDY OF QUALITATIVE PATIENT INTERVIEWS EMBEDDED WITHIN A NEUROFIBROMATOSIS 2 CLINICAL TRIAL حسب Merker, Vanessa, Von Imhof, Liesel, Park, Elyse, Babovic-Vuksanovic, Dusica, NghiemPhu, PhiOanh [Leia], Yohay, Kaleb, Plotkin, Scott
منشور في 2022نص -
20
Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth حسب James, Marianne F., Lelke, Johanna M., MacCollin, Mia, Plotkin, Scott R., Stemmer-Rachamimov, Anat O., Ramesh, Vijaya, Gusella, James F.
منشور في 2007نص